No Data
No Data
The Market Doesn't Like What It Sees From Myriad Genetics, Inc.'s (NASDAQ:MYGN) Revenues Yet As Shares Tumble 33%
New Analyst Forecast: $MYGN Given $12.5 Price Target
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?
Analyst Sees Bottom For Myriad Genetics Stock, Issues Upgrade
Sector Update: Health Care Stocks Lower Late Afternoon
Why Are Myriad Genetics (MYGN) Shares Soaring Today